JPMORGAN CHASE & CO - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is and the CUSIP is 91911K902. A total of 6 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q3 2017$630,000
-98.5%
45,800
-98.2%
0.00%
-100.0%
Q2 2017$42,904,000
+56.8%
2,480,0000.0%0.01%
+66.7%
Q1 2017$27,354,000
+224.8%
2,480,000
+327.6%
0.01%
+200.0%
Q4 2016$8,422,000
-40.9%
580,0000.0%0.00%
-50.0%
Q3 2016$14,239,000
+497.0%
580,000
+539.5%
0.00%
+300.0%
Q1 2016$2,385,000
-98.9%
90,700
-95.9%
0.00%
-98.2%
Q4 2015$223,630,000
+334.1%
2,200,000
+661.8%
0.06%
+300.0%
Q3 2015$51,516,000288,8000.01%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q3 2017
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 1,425$12,266,0000.82%
GROUP ONE TRADING, L.P. 127,400$10,967,0000.27%
KNIGHT CAPITAL GROUP LLC 23,200$1,997,0000.04%
Timber Hill LLC 92,700$7,980,0000.03%
Citadel Advisors 131,000$11,276,0000.02%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders